Roche, Bristol-Myers Melanoma Treatments Lead to Longer Lives: "An experimental drug from Roche Holding AG and Daiichi Sankyo Co. boosted survival of patients with melanoma in a study, a result that may lead to a second new treatment to fight deadly skin cancer."
Comments